Skip to main content
. 2023 Sep 19;11(11):7283–7295. doi: 10.1002/fsn3.3654

TABLE 3.

Clinical and dietetic parameters of prediabetic volunteers submitted to Eriomin® or Placebo daily supplements for 12 weeks.

Variables Placebo Eriomin®
0 week 12°week 0 week 12°week
Biometric
Systolic BP, mmHg 125 ± 10 124 ± 11 102 ± 25 102 ± 26
Diastolic BP, mmHg 78.0 ± 7.9 74.0 ± 7.7 79.0 ± 9.4 77.0 ± 9.5
Body weight, kg 103 ± 17 104 ± 17 102 ± 25 102 ± 26
BMI, kg/m2 34.5 ± 6.5 34.5 ± 6.7 34.5 ± 7.1 34.5 ± 7.3
Lean mass, kg 34.5 ± 7.3 34.7 ± 7.4 34.9 ± 6.7 34.9 ± 7.3
Fat mass, kg 37.7 ± 8.9 38.3 ± 15.6 40.1 ± 17.8 39.3 ± 18.6
Waist/Hip 1.05 ± 0.10 1.05 ± 0.09 1.06 ± 0.08 1.06 ± 0.09
Nutritional
Energy, kcal/day 3538 ± 932 3500 ± 927 3180 ± 855 3249 ± 1006
(TEE, kcal/day) (2453 ± 320) (2383 ± 392) (2318 ± 356) (2419 ± 306)
Carbohydrates, g/day 380 ± 82 415 ± 126 374 ± 119 360 ± 98
(AMDR = 45–65%TEE) (44 ± 8%) (48 ± 10%) (47 ± 6%) (46 ± 9%)
Protein, g/day 143 ± 52 138 ± 46 135 ± 45 135 ± 45
(AMDR = 10–35%TEE) (16 ± 3%) (16 ± 4%) (17 ± 3%) (17 ± 5%)
Lipids 162 ± 66 145 ± 38 129 ± 35 142 ± 76
(AMDR = 20–35% TEE) (40 ± 8%) (38 ± 11%) (36 ± 6%) (42 ± 25%)
Saturated Fat Acids 37 ± 16 49 ± 12 40 ± 10 44 ± 20
(AHA ≤7% TEE) (13 ± 3%) (13 ± 4%) (11 ± 2%) (13 ± 7%)
Fibers, g/day 17.8 ± 3.3 19.5 ± 3.9 19.6 ± 3.0 19.4 ± 3.8
(AI = 25 g/day) Below Below Below Below
Cholesterol, mg/day 566 ± 188 554 ± 117 553 ± 156 504 ± 118
(AHA ≤ 200 mg/day) Above Above Above Above

Note: Data presented as mean ± SD. The values in (italic) represent % of macronutrient energy (kcal/day) regarding the Total Energy Expenditure (TEE). No statistic differences detected intragroup (week 0 vs. 12) or intergroups (Eriomin vs. Placebo) (p ≥ .05).

Abbreviations: AHA, American Heart Association; AI, Adequate Intake; AMDR, acceptable macronutrient distribution ranges; TEE, total energy expenditure (kcal/day).